Is Pmv Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: PMVP) stock is to Strong Buy PMVP stock.
Out of 2 analysts, 1 (50%) are recommending PMVP as a Strong Buy, 1 (50%) are recommending PMVP as a Buy, 0 (0%) are recommending PMVP as a Hold, 0 (0%) are recommending PMVP as a Sell, and 0 (0%) are recommending PMVP as a Strong Sell.
What is PMVP's forecast return on equity (ROE) for 2024-2025?
(NASDAQ: PMVP) forecast ROE is -40.8%, which is considered weak.
What is PMVP's Price Target?
According to 2 Wall Street analysts that have issued a 1 year PMVP price target, the average PMVP price target is $6.00, with the highest PMVP stock price forecast at $7.00 and the lowest PMVP stock price forecast at $5.00.
On average, Wall Street analysts predict that Pmv Pharmaceuticals's share price could reach $6.00 by Mar 7, 2025. The average Pmv Pharmaceuticals stock price prediction forecasts a potential upside of 263.64% from the current PMVP share price of $1.65.
What is PMVP's forecast return on assets (ROA) for 2024-2025?
(NASDAQ: PMVP) forecast ROA is -36.52%, which is lower than the forecast US Biotechnology industry average of 9.48%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.